{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:48:08Z","timestamp":1770266888530,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1124\/jpet.105.083964","type":"journal-article","created":{"date-parts":[[2005,6,17]],"date-time":"2005-06-17T02:07:56Z","timestamp":1118974076000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N\u2032-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke"],"prefix":"10.1016","volume":"314","author":[{"given":"Noriyuki","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kagumi","family":"Bandou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Kametani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Cambj-Sapunar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.083964_bib1","doi-asserted-by":"crossref","unstructured":"Aspey BS, Alp MS, Patel Y, and Harrison MJ (1997) Effects of combined glutamate and platelet activating factor inhibition on the outcome of focal cerebral ischaemia- and initial screening. Metab Brain Dis 12: 237-249.","DOI":"10.1023\/B:MEBR.0000007104.75056.e4"},{"key":"10.1124\/jpet.105.083964_bib2","doi-asserted-by":"crossref","unstructured":"Broderick JP, Brott TG, Duldner JE, Tomsick T, and Leach A (1994) Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25: 1342-1347.","DOI":"10.1161\/01.STR.25.7.1342"},{"key":"10.1124\/jpet.105.083964_bib3","doi-asserted-by":"crossref","unstructured":"Cambj-Sapunar L, Yu M, Harder DR, and Roman RJ (2003) Contribution of 5-hydroxy-tryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34: 1269-1275.","DOI":"10.1161\/01.STR.0000065829.45234.69"},{"key":"10.1124\/jpet.105.083964_bib4","doi-asserted-by":"crossref","unstructured":"Crespi CL, Miller VP, and Penman BW (1997) Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 248: 188-190.","DOI":"10.1006\/abio.1997.2145"},{"key":"10.1124\/jpet.105.083964_bib5","doi-asserted-by":"crossref","unstructured":"Del Bigio MR, Yan HJ, Buist R, and Peeling J (1996) Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates. Stroke 27: 2312-2319.","DOI":"10.1161\/01.STR.27.12.2312"},{"key":"10.1124\/jpet.105.083964_bib6","doi-asserted-by":"crossref","unstructured":"Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, et al. (2000) Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87: 60-65.","DOI":"10.1161\/01.RES.87.1.60"},{"key":"10.1124\/jpet.105.083964_bib7","doi-asserted-by":"crossref","unstructured":"Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, and Harder DR (1998) Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol (Lond) 507: 771-781.","DOI":"10.1111\/j.1469-7793.1998.771bs.x"},{"key":"10.1124\/jpet.105.083964_bib8","doi-asserted-by":"crossref","unstructured":"Guyot LL, Diaz FG, O\u2019Regan MH, McLeod S, Park H, and Phillis JW (2001) Real time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model. Neurosci Lett 299: 37-40.","DOI":"10.1016\/S0304-3940(01)01510-5"},{"key":"10.1124\/jpet.105.083964_bib9","unstructured":"Hacein-Bey L, Harder DR, Meier HT, Lauer KK, and Roman RJ (2004a) Improvement in angiographic vasospasm with a 20-HETE enzyme inhibitor in a subarachnoid hemorrhage dog model (Abstract 59). Proceedings of the American Society of Neuroradiology; 2004 Jun 5\u201311; Seattle, WA. p 46, oral presentation, American Society of Neuroradiology 42nd Meeting."},{"key":"10.1124\/jpet.105.083964_bib10","unstructured":"Hacein-Bey L, Roman RJ, Lemke DM, Lauer KK, Varelas PN, Torbey MT, Cusick JF, and Harder DR (2004b) Evaluation of 20-hydroxyeiscosatetraenoic acid (20-HETE) levels in normal and abnormal blood and CSF (Abstract 66). Proceedings of the American Society of Neuroradiology; 2004 Jun 5\u201311; Seattle, WA. p 51, oral presentation, American Society of Neuroradiology 42nd Meeting."},{"key":"10.1124\/jpet.105.083964_bib11","doi-asserted-by":"crossref","unstructured":"Jenkins A, Maxwell WL, and Graham DI (1989) Experimental intracerebral haematoma in the rat: sequential light microscopical changes. Neuropathol Appl Neurobiol 15: 477-486.","DOI":"10.1111\/j.1365-2990.1989.tb01247.x"},{"key":"10.1124\/jpet.105.083964_bib12","doi-asserted-by":"crossref","unstructured":"Kehl F, Cambji-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, et al. (2002) 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol 282: H1556-H1565.","DOI":"10.1152\/ajpheart.00924.2001"},{"key":"10.1124\/jpet.105.083964_bib13","doi-asserted-by":"crossref","unstructured":"Kristian T, Gido G, Kuroda S, Schutz A, and Siesjo BK (1998) Calcium metabolism of focal and penumbral tissues in rats subjected to transient middle cerebral artery occlusion. Exp Brain Res 120: 503-509.","DOI":"10.1007\/s002210050424"},{"key":"10.1124\/jpet.105.083964_bib14","doi-asserted-by":"crossref","unstructured":"Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, and Powell PK (2000) Formation of 20-hyroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: role of Cyp4F2 and Cyp4A11. J Biol Chem 275: 4118-4126.","DOI":"10.1074\/jbc.275.6.4118"},{"key":"10.1124\/jpet.105.083964_bib15","doi-asserted-by":"crossref","unstructured":"Liu XH, Eun BL, Silverstein FS, and Barks JD (1996b) The platelet activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatric Res 40: 797-803.","DOI":"10.1203\/00006450-199612000-00004"},{"key":"10.1124\/jpet.105.083964_bib16","doi-asserted-by":"crossref","unstructured":"Liu Y, Mituska S, Hashizume K, Hosaka T, and Nukui H (1996a) The time course of glucose metabolism in rat cerebral ischemia with middle cerebral artery occlusion-reperfusion model and the effect of MK-801. Neurol Res 18: 505-508.","DOI":"10.1080\/01616412.1996.11740462"},{"key":"10.1124\/jpet.105.083964_bib17","doi-asserted-by":"crossref","unstructured":"Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, and Roman RJ (2000) Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 279: H863-H871.","DOI":"10.1152\/ajpheart.2000.279.2.H863"},{"key":"10.1124\/jpet.105.083964_bib18","doi-asserted-by":"crossref","unstructured":"Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, et al. (2001) HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 133: 325-329.","DOI":"10.1038\/sj.bjp.0704101"},{"key":"10.1124\/jpet.105.083964_bib19","doi-asserted-by":"crossref","unstructured":"Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, and Malik KU (1998) 20-HETE mediates calcium\/calmodulin dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95: 12701-12706.","DOI":"10.1073\/pnas.95.21.12701"},{"key":"10.1124\/jpet.105.083964_bib20","doi-asserted-by":"crossref","unstructured":"Nagasawa H and Kogure K (1989) Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20: 1037-1043.","DOI":"10.1161\/01.STR.20.8.1037"},{"key":"10.1124\/jpet.105.083964_bib21","doi-asserted-by":"crossref","unstructured":"Nakamura T, Sato M, Kakinuma H, Miyata N, Taniguchi K, Bando K, Koda A, and Kameo K (2003) Pyrazole and isoxazole derivatives as new, potent and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors. J Med Chem 46: 5416-5427.","DOI":"10.1021\/jm020557k"},{"key":"10.1124\/jpet.105.083964_bib22","doi-asserted-by":"crossref","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587.","DOI":"10.1056\/NEJM199512143332401"},{"key":"10.1124\/jpet.105.083964_bib23","doi-asserted-by":"crossref","unstructured":"Patel TR, Galbraith S, Graham DI, Hallak H, Doherty AM, and McCulloch J (1996) Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab 16: 950-958.","DOI":"10.1097\/00004647-199609000-00019"},{"key":"10.1124\/jpet.105.083964_bib24","doi-asserted-by":"crossref","unstructured":"Peeling J, Yan HJ, Chen SG, Campbell M, and Del Bigio MR (1998) Protective effects of free radical inhibitors in intracerebral hemorrhage in rat. Brain Res 795: 63-70.","DOI":"10.1016\/S0006-8993(98)00253-4"},{"key":"10.1124\/jpet.105.083964_bib25","doi-asserted-by":"crossref","unstructured":"Pilitsis JG, Coplin WM, O\u2019Regan MH, Wellwood JM, Diaz FG, Fairfax MR, Michael DB, and Phillis JW (2003) Measurement of free fatty acids in cerebrospinal fluid from patients with hemorrhagic and ischemic stroke. Brain Res 985: 198-201.","DOI":"10.1016\/S0006-8993(03)03044-0"},{"key":"10.1124\/jpet.105.083964_bib26","doi-asserted-by":"crossref","unstructured":"Randriambozvonjy V, Busse R, and Fleming I (2003) 20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase. Hypertension 41: 801-806.","DOI":"10.1161\/01.HYP.0000047240.33861.6B"},{"key":"10.1124\/jpet.105.083964_bib27","unstructured":"Sarvary E, Halsey JH, Conger KA, Garcia JH, and Kovach AG (1994) ATP and pH predictors of histologic damage following global cerebral ischemia in the rat. Acta Physiol Hung 82: 109-124."},{"key":"10.1124\/jpet.105.083964_bib28","doi-asserted-by":"crossref","unstructured":"Shino A, Matsuda M, Susumu T, and Handa J (1991) Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats. Surg Neurol 35: 105-110.","DOI":"10.1016\/0090-3019(91)90259-C"},{"key":"10.1124\/jpet.105.083964_bib29","doi-asserted-by":"crossref","unstructured":"Shirakura S, Sano J, Karasawa A, and Kubo K (1992) Protective effect of benidipine on arachidonic acid-induced acute cerebral ischemia in rats. Jpn J Pharmacol 59: 15-22.","DOI":"10.1254\/jjp.59.15"},{"key":"10.1124\/jpet.105.083964_bib30","doi-asserted-by":"crossref","unstructured":"Su P, Kaushal KM, and Kroetz DL (1998) Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol Regul Integr Comp Physiol 275: R426-R438.","DOI":"10.1152\/ajpregu.1998.275.2.R426"},{"key":"10.1124\/jpet.105.083964_bib31","doi-asserted-by":"crossref","unstructured":"Sun CW, Falck JR, Harder DR, and Roman RJ (1999) Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33: 414-418.","DOI":"10.1161\/01.HYP.33.1.414"},{"key":"10.1124\/jpet.105.083964_bib32","doi-asserted-by":"crossref","unstructured":"Tseng EE, Brock MV, Kwon CC, Annanata M, Lange MS, Troncoso JC, Johnston MV, and Baumgartner WA (1999) Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest. Ann Thorac Surgery 67: 372-376.","DOI":"10.1016\/S0003-4975(99)00033-8"},{"key":"10.1124\/jpet.105.083964_bib33","doi-asserted-by":"crossref","unstructured":"Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, and Schwartzman ML (1998) Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 284: 966-973.","DOI":"10.1016\/S0022-3565(24)37347-1"},{"key":"10.1124\/jpet.105.083964_bib34","doi-asserted-by":"crossref","unstructured":"Werling LL, Jacocks HM, Rosenthal RE, and Fiskum G (1993) Dopamine release from canine striatum following global cerebral ischemia\/reperfusion. Brain Res 606: 99-105.","DOI":"10.1016\/0006-8993(93)91575-D"},{"key":"10.1124\/jpet.105.083964_bib35","doi-asserted-by":"crossref","unstructured":"Xu F, Straub WO, Pa W, Su P, Maier KG, Yu M, Roman RJ, Ortiz de Montellano PR, and Kroetz DL (2002) Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid \u03c9-hydroxylase activity. Am J Physiol Regul Integr Comp Physiol 283: R710-R720.","DOI":"10.1152\/ajpregu.00522.2001"},{"key":"10.1124\/jpet.105.083964_bib36","doi-asserted-by":"crossref","unstructured":"Yu M, Cambj-Sapunar L, Kehl F, Maier KG, Takeuchi K, Miyata N, Ishimoto T, Reddy LM, Falck JR, Gebremedhin D, et al. (2004) Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol 486: 297-306.","DOI":"10.1016\/j.ejphar.2004.01.009"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524320609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524320609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.083964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:29:01Z","timestamp":1740000541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524320609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0022356524320609"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.083964","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N\u2032-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.083964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}